Centralized leadership and support for cancer research in Nigeria
Official title: Administrative Core
Funded at Sloan-Kettering Inst Can Research · NIH-10879523 · Data updated 2026-11-12
This study is working to improve cancer care in Nigeria by bringing together a team of experts to explore how the immune system fights cancer and to understand the differences in cancer experiences between patients in Nigeria and the US, all while building better research resources and partnerships.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 16, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $129,911 |
| NIH project number | 1P20CA290448-01 |
| Project ID | NIH-10879523 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Nigerian cancer patients, particularly those affected by colorectal cancer and other disparities.
✕Less likely to help
Patients outside of Nigeria or those not affected by cancer may not receive direct benefits from this research.
What this research studies
This research initiative focuses on enhancing cancer research and capacity-building in Nigeria through a centralized administrative core. It aims to assemble a multidisciplinary team to investigate immuno-oncology and health disparities between Nigerian and US cancer patients. The program will develop the necessary infrastructure for conducting research and foster collaborations among various institutions. By leveraging existing expertise and resources, the initiative seeks to improve cancer care and research capabilities in Nigeria.
Why it matters
Potential benefit: If successful, this research could significantly improve cancer treatment and outcomes for patients in Nigeria and beyond.
How similar studies have gone: Previous research initiatives in similar contexts have shown promise in improving cancer care and addressing health disparities.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Kingham, T Peter — Sloan-Kettering Inst Can Research
- Study coordinator: Kingham, T Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.